Product Information
RHOPRESSA 0.02% OPHTH SOLUTION is a brand product labeled by Alcon Laboratories, Inc., priced at $131.7017 per ML under NDC 70727049725. Its NADAC has been published 402 times since Oct 17, 2018.
Strength
.2 mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
70727049725
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC; TOPICAL
Last Updated
6/17/2026
Active Ingredients
NETARSUDIL MESYLATEApproval Type
New Drug (NDA)
FDA Application
NDA208254On Market Since
12/18/2017
Pharmacological Classes
Price Statistics
The NADAC for RHOPRESSA 0.02% OPHTH SOLUTION has been published 402 times since Oct 17, 2018, and over the history we have for it it has risen 50.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $131.7017 per ML |
|---|---|
| All-time high | $131.9200 (May 13, 2026) |
| All-time low | $87.7131 (Oct 17, 2018) |
| 52-week high | $131.9200 |
| 52-week low | $128.0208 |
| Median price | $114.0860 |
| Average price | $114.4158 |
| Largest weekly change | +9.0% (Nov 28, 2018) |
| Weeks tracked | 402 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the netarsudil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RHOPRESSA 0.02% OPHTH SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for RHOPRESSA 0.02% OPHTH SOLUTION, manufactured by Alcon Laboratories, Inc., is $131.7017 per ML (NDC 70727049725), effective Jun 24, 2026.
How has the price of RHOPRESSA 0.02% OPHTH SOLUTION changed over time?
Over the history we have for it, the NADAC for RHOPRESSA 0.02% OPHTH SOLUTION has risen 50.2%. It has been tracked across 402 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for RHOPRESSA 0.02% OPHTH SOLUTION?
Since Oct 17, 2018, the NADAC for RHOPRESSA 0.02% OPHTH SOLUTION has ranged from a low of $87.7131 (Oct 17, 2018) to a high of $131.9200 (May 13, 2026), with a median of $114.0860 per ML.
Are there cheaper alternatives to RHOPRESSA 0.02% OPHTH SOLUTION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RHOPRESSA 0.02% OPHTH SOLUTION, so no direct lower-cost alternative is listed.
Who manufactures RHOPRESSA 0.02% OPHTH SOLUTION?
RHOPRESSA 0.02% OPHTH SOLUTION (NDC 70727049725) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification